Evidence map›Paper›PMID 34208093›Full record

ArticleMicroorganisms2021

Claudie Lamoureux, Charles-Antoine Guilloux, Elise Courteboeuf, Stéphanie Gouriou, Clémence Beauruelle, Geneviève Héry-Arnaud

Abstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Bridging the gap:Gut microbes · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Proteome level analysis of drug-resistantFrontiers in microbiology · 2023
    Article
  8. Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation.Journal of the Pediatric Infectious Diseases Society · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Claudie LamoureuxUniv Brest, INSERM, EFS, UMR 1078, GGB, 29200 Brest, France.
Charles-Antoine GuillouxUniv Brest, INSERM, EFS, UMR 1078, GGB, 29200 Brest, France.
Elise CourteboeufUniv Brest, INSERM, EFS, UMR 1078, GGB, 29200 Brest, France.
Stéphanie GouriouUniv Brest, INSERM, EFS, UMR 1078, GGB, 29200 Brest, France.
Clémence BeauruelleUniv Brest, INSERM, EFS, UMR 1078, GGB, 29200 Brest, France.
Geneviève Héry-ArnaudUniv Brest, INSERM, EFS, UMR 1078, GGB, 29200 Brest, France.

Funding

Association Vaincre la Mucoviscidose RC20180502218
6 · The paper itself

Abstract

The importance and abundance of strict anaerobic bacteria in the respiratory microbiota of people with cystic fibrosis (PWCF) is now established through studies based on high-throughput sequencing or extended-culture methods. In CF respiratory niche, one of the most prevalent anaerobic genera is

Indexed as

antibiotics susceptibilitycystic fibrosisPrevotella melaninogenicaresistance

Identifiers

PMID34208093
PMCPMC8230849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.